Nolato has entered into an agreement to acquire Poland-based Grizzly Medical, which is involved in the assembly, post-processing and quality assurance of medical device components and systems. The company, which has annual sales of around SEK 25 million and 90 employees, has been a supplier to and partner of Nolato Medical since the 1990s. “This is a relatively small but strategically important acquisition that boosts our capacity in the low-volume, clean room-based production segment, including assembly and post-processing, giving us an even more comprehensive customer offering. We are seeing growing demand for complex products and systems that require manual or semi-automated processing, and we believe this company will be an important part of Nolato’s future growth strategy,” said Nolato President and CEO Christer Wahlquist. Grizzly Medical was founded in 1996 and is estimated to have sales of around SEK 25 million for 2016, with good profitability. The company has 90 employees at its plant in Stargard in north-west Poland and the majority of its production takes place in a clean room environment. The purchase price is SEK 14 million and the business will be consolidated into Nolato from 1 September. The company will operate under the name Nolato Stargard and will be led by the current management. “Acquisitions are a natural part of Nolato’s growth strategy and we are continually working to acquire additional operations that both fit our growth strategy and strengthen our overall customer offering. Nolato has a healthy financial position, which provides considerable flexibility to make significant acquisitions if there is an opportunity to increase shareholder value in both the short and long term,” said Nolato President and CEO Christer Wahlquist. --------- For further information, please contact: Christer Wahlquist, President and CEO, +46 (0)705 804848 Per-Ola Holmström, CFO, +46 (0)705 763340 Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Mid Cap segment, where they are included in the Industrials sector. This information is information that Nolato AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 8.30 am CET on 2 September, 2016. www.nolato.com
Nolato strengthens overall customer offering Nolato has
Top 10 Most Recent News Articles
Short Term Shop Hits $500M in Airbnb Sales Milestone
Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...
Continue Reading
Saddleback's Bold Doula Program: A Game Changer
Revolutionizing Maternity Support at Saddleback Saddleback Medical Center in Laguna Hills, California, is stirring the waters with its groundbreaking expansion in maternity services. For the first time, an Orange County hospital—The Women’s Hospital at MemorialCare Saddleback Medical Center—is offering complimentary, around-the-clock in-house doulas. Not a luxury,...
Continue Reading
Arbor Scientia Snags Second Consecutive BASA Win
Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...
Continue Reading
Hyliion Partnership Woes: Investors Eye Legal Options
Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...
Continue Reading
Florida Leaders Set Sights on Top 10 Economy by 2030
Florida's Ambitious Economic Goals When someone floats the idea of a state's economy cracking the top 10 globally by the year 2030, you've got to wonder if it's all sunshine and rainbows, or if there's some serious groundwork being laid. The Florida Chamber Foundation seems to think it's achievable. As the end of October rolls around, they're throwing the 2026 Future of...
Continue Reading
CourseArc Partners with Colleges for ADA Compliance
CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...
Continue Reading
Oberndorf, Bascom Snap Up San Jose Flats for $53M
Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...
Continue Reading
MSA Safety to Reveal Q3 2026 Earnings on Nov. 3
MSA Gears Up for Q3 Earnings Call—Why It Matters At the crack of dawn on November 3, 2026, MSA Safety Incorporated (NYSE: MSA) is set to unravel the latest updates on their financial frontline. For those keeping a sharp eye on the safety gear behemoth, this isn’t just another earnings call—it's the kind of event that can make or break confidence in their stock....
Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026
Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...
Continue Reading
VIVIFY and ELISIUM Plan Hydrogen-Powered City
Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...
Continue ReadingTop 5 Most Recently Viewed Articles
Innovative Breakthrough: MTX-201 Data Unveiled at Congress
Exciting Developments from Mozart Therapeutics Recent findings from Mozart Therapeutics shine a spotlight on MTX-201, a groundbreaking bispecific antibody designed to treat inflammatory bowel disease (IBD). This innovative therapy selectively binds to CD8 regulatory T cells (Treg), with the potential to effectively eliminate pathogenic CD4 T cells and lessen inflammation,...
Continue Reading
Arixa Capital Celebrates Major Loan Milestone and Expansion
Arixa Capital Achieves New Heights in Loan Originations Arixa Capital, a prominent private real estate lender, has officially crossed the impressive milestone of over $7 billion in total loan originations since its establishment. This remarkable achievement underscores the firm's commitment to providing flexible and reliable financing solutions to real estate...
Continue Reading
Synaffix Partners with Illumina to Advance DNA Sequencing Tech
Synaffix and Illumina Join Forces for Breakthrough Technologies Synaffix B.V., a prominent biotechnology company renowned for its innovative clinical-stage bioconjugation platform technology, has announced a licensing agreement with Illumina, Inc., a leader in DNA sequencing technologies. This agreement allows Illumina access to Synaffix's patented metal-free click...
Continue Reading
Bristol Myers Squibb Gains Approval for Opdivo and Yervoy Combo
Bristol Myers Squibb Gaining Traction in Colorectal Cancer Treatment Bristol Myers Squibb (NYSE: BMY) has recently secured a significant win by obtaining approval from the European Commission (EC) for its leading immunotherapy combinations. This approval is specifically for the use of Opdivo (nivolumab) combined with Yervoy (ipilimumab) as a first-line treatment option...
Continue Reading
Hillary F. Blackburn Joins ACIP as First Pharmacist Member
Hillary F. Blackburn's Significant New Role The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have made an important announcement. They have appointed Hillary F. Blackburn, PharmD, MBA, as the first pharmacist voting member of the Advisory Committee on Immunization Practices (ACIP). This historic appointment...
Continue Reading